Navigation Links
BioLineRx Presents Phase I Clinical Data of BL-1020 at Upcoming,Clinical Conferences

available typical and atypical antipsychotic drugs while achieving a much higher safety profile as evidenced by a lack of metabolic or extrapyramidal side effects.

BL-1020 is being developed by BioLineRx, Ltd. under a worldwide exclusive license from Ramot at Tel Aviv University Ltd. and Bar-Ilan Research and Development Company Ltd., the technology transfer arms of Tel Aviv University and Bar-Ilan University respectively. BL-1020 was discovered by Professor Abraham Nudelman from the Department of Chemistry, Bar-Ilan University; and Ada Rephaeli, Ph.D., Professor Abraham Weizman, MD, and Irit Gil-Ad, Ph.D. from the Sackler Faculty of Medicine, Tel Aviv University.

About BioLineRx

BioLineRx, a clinical stage drug development company traded on the Tel Aviv Stock Exchange (TASE: BLRX), is dedicated to building a robust pipeline of promising therapeutics for unmet medical needs. The Company's leading programs are for schizophrenia and treatment of damaged heart tissue post-myocardial infarction. Additional products under development include compounds for the treatment of cancer and CNS, cardiovascular, metabolic, infectious and autoimmune diseases.

BioLineRx advances projects from early stage discovery and lead generation to advanced clinical trials, regulatory approval and marketing. Partnering with researchers, universities and biotech companies to further the commercialization of promising compounds, BioLineRx seeks to enrich the pipeline of large pharmaceutical companies seeking their next blockbuster drugs. The Company was founded in 2003 by leaders in the Israeli life science arena including Teva Pharmaceuticals Ltd, Giza, Pitango, Hadasit and the Jerusalem Development Authority. For more information, please visit www.biolinerx.com.

This press release contains "forward-looking statements." These statements include words like "may," "expects," "believes," "scheduled" and "intends," and describe opinions about future events. These
'"/>




Page: 1 2 3

Related medicine technology :

1. BioLineRx Presents Data From Successful Phase I Trial for BL-1020 in Schizophrenia at American Psychiatric Association Conference
2. BioLineRx Presents Data on BL-1040 at Cardiovascular Revascularization Therapies Conference Demonstrating Potential to Reduce Deterioration of Infarcted Heart Tissue and Maintain Functionality
3. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
4. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
5. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
6. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
7. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
8. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
9. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
10. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
11. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting

Post Your Comments:
(Date:11/25/2009)...SKINGRIDGE,N.J.,Nov.25/PRNewswire/--RegadoBioscien...tithromboticaptamerswithactivecontrolagents,announ...tingatthePiperJaffray21stAnnualHealthCareConferenc...esentationwillbegivenat1:10pm(EST)onTuesday,Decemb...ithemphasisontheleaddevelopmentprogram,theanticoag...
(Date:11/25/2009)...WYORK,Nov.25/PRNewswire/--Reportlinker.comannounce...ogue: ,, UnitedStatesDentalDevicesMarketAnalys...er.com/p0158733/United-States-Dental-Devices-Marke...dStatesDentalDevicesMarketAnalysisandForecaststo20...urceforin-depthinformationanddatarelatingtotheUSde...
(Date:11/25/2009)...IONCITY,Calif.,Nov.25/PRNewswire-FirstCall/--Abaxi...acturingpoint-of-carebloodanalysissystems,announce...fficer,willpresentatthe21stAnnualPiperJaffrayHealt....ET.TheconferencewillbeheldattheNewYorkPalaceHotel...elops,manufacturesandmarketsportablebloodanalysiss...
Breaking Medicine Technology:Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12Oberthur Technologies and Groupe Sephira Team up to Deliver a Secured Electronic Billing Solution 60667 1Oberthur Technologies and Groupe Sephira Team up to Deliver a Secured Electronic Billing Solution 60667 2Monsanto Opens First Biotechnology Research Center in China 14714 1Monsanto Opens First Biotechnology Research Center in China 14714 2Monsanto Opens First Biotechnology Research Center in China 14714 3New scientific study indicates that eating quickly is associated with overeating 60665 1New scientific study indicates that eating quickly is associated with overeating 60665 2
...MAN, N.J., Jan. 11 According to the American,Acad...ld,s population,suffers from eczema, an inflamed s...y skin. To help manage the condition,s symptoms, w...(R), the leader in ACTIVE NATURALS(R),has introduc...h, formulated,with hydrating ingredients to help m...
...ative Concepts for ER One to be Studied for First ...ting, WASHINGTON, Jan. 10 Washington Hospital Ce...lly funded Project ER One initiative,as it unveile...its,Emergency Department. These advances are meant...hospital to respond to a mass casualty event in th...
Other Medicine Technology:New AVEENO(R) Eczema Care Product Line Offers Breakthrough Formulas to Help Manage the Signs and Symptoms of Eczema 2Hospital Launches Landmark Emergency Medicine Project 2Hospital Launches Landmark Emergency Medicine Project 3
(Date:11/26/2009)... Benton Communications announces a hi...system for retailers struggling to make an economi...ember 26, 2009 -- Flu fears is the type of challen...rgency room, according to Dr. David Benton, busine...business growth system – The Rfactor Intens...
(Date:11/25/2009)...ASCITY,Mo.,Nov.25/PRNewswire/--TheBartleHallConven...edicalcliniconDec.9-10,whenKansasCityhoststhelates...,, "Thisfreecliniceventhasthepotentialtobethebi...fjustoneandbeheldonweekdaysinsteadofoveraweekend,"...thClinicandpresidentoftheNationalAssociationofFree...
(Date:11/25/2009)...NTO,Nov.25/PRNewswire/-SentinelleMedicalInc.,alead...ationsoftwarelaunchesasuiteofnewleadingedgeclinica...latformatthisyear,sRadiologicalSocietyofNorthAmeri...ooth5800,HallA).Theapplicationsleveragetheuniquehi...RIimagingcoilsandsupportmultipleimagingmodalitiesf...
(Date:11/25/2009)...NGELES,Nov.25/PRNewswire-USNewswire/--TheBlackAIDS...ermineexecutiveleadershipfor2010. ,, ThenewBoar...tiesinpublicpolicy,law,finance,governmenthealthpro...rdalsocomesfromawiderangeofpersonalbackgroundsincl...vingwithHIVthemselves,andrepresentingmultipleagegr...
(Date:11/25/2009)...survivors of testicular cancer who were treated wi...de effects, including neurological side effects an...eated with chemotherapy, according to a new study ...e National Cancer Institute . , Marianne Brydy, ...versity Hospital, in Bergen, Norway, and colleague...
Breaking Medicine News(10 mins):Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Black AIDS Institute Announces 2010 Board Election Results 2
...eport publishing online on February 12th in the jo... counterintuitive new method to make cancer less l...s, blood vessels to improve their oxygen supply. S...ork by cutting off the growth of new blood vessels...
...AGO, Feb. 12 Resurrection Health Care (RHC) and M...o open a network of sleep testing facilities that ... , As part of the agreement, Resurrection and Meri...ep center network size to 25 locations before the ...
...YORK, Feb. 12 Medicare now pays for treatments de...change that and apply a cost-effectiveness standar...ng Council for Comparative Effectiveness Research....s using a formula that divides the cost of treatme...
... , , , , The Final Inch and Slumdog Millionaire...initiative , , EVANSTON, Ill., Feb. 12 Astute...o eradication this year, thanks to two nominated f... , The Final Inch, nominated for an Academy Awa...
...NESVILLE, Fla. Women who as children got radiatio...mes more likely than others to develop breast canc...including the University of Florida. , The highe...s always to get rid of the cancer. Our second prio...
...MELBOURNE, Fla., Feb. 12 Harris Corporation,(NYSE...ormation technology,company, has been awarded a te... First, a not-for-profit healthcare system, to pro...tract includes,software and hardware support, 24/7...
Other Medicine News:Health News:'Normalizing' tumor vessels leaves cancer more benign 2Health News:Oscar Nominated Films Raise Polio Awareness 2Health News:Pediatric Hodgkin's disease survivors face increased breast cancer risk 2Health News:Pediatric Hodgkin's disease survivors face increased breast cancer risk 3Health News:Health First Healthcare System Awards Harris Corporation Enterprise-wide Network Management and IT Services Contract 2Health News:Health First Healthcare System Awards Harris Corporation Enterprise-wide Network Management and IT Services Contract 3
...l processing. Olympus wide array of high-quality c...and flexibility you need for an efficient viewing ...olution, real-time image of your specimen that can...can even record movies when these easy-to-operate ...
...age quality at low light intensity. DFC350 F mono-...ned for imaging applications where limited light i...right, vibrant images without noise or color aberr...a cameras allow dark and light objects to be recor...
...age quality at low light intensity. Leica DFC300 F...cally designed for imaging applications where limi...cs create bright, vibrant images without noise or ...by the Leica cameras allow dark and light objects ...
...era system for high resolution photomicrography. T...ges of the highest color fidelity, resolution and ...ect perfect images due to many unique Leica featur...ative readout modes. The Leica DFC480 is ideal for...
Medicine Products: